Loading clinical trials...
Loading clinical trials...
In this study the investigators explore a pragmatic strategy to increase cognitive screening rates in the community. The investigators will compare the monetary value of different combinations of SCD ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ludwig-Maximilians - University of Munich
Collaborators
NCT07279714 · Alzheimer s Disease, Alzheimer Dementia, and more
NCT06669546 · Cognitive Decline, Alzheimer Disease, and more
NCT07457138 · Subjective Cognitive Decline (SCD), Functional Cognitive Disorder, and more
NCT04838301 · Alzheimer Dementia, Late Onset Alzheimer Disease, and more
NCT07286448 · Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)
Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums
München, Bavaria
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions